In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides.

Billioud, Gaetan

In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. [electronic resource] - Journal of hepatology Apr 2016 - 781-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1600-0641

10.1016/j.jhep.2015.11.032 doi


Animals
Hep G2 Cells
Hepatitis B Surface Antigens--blood
Hepatitis B e Antigens--blood
Hepatitis B, Chronic--drug therapy
Humans
Mice
Oligonucleotides, Antisense--therapeutic use
Viremia--drug therapy